Moreover, on actually using the SYA as the antioxidant to against INH-induced hepatotoxicity, the potentially incompatible pharmacokinetics of the two compounds may also make the protective effect further be reduced [15].
Moreover, on actually using the SYA as the antioxidant to <br>against INH-induced hepatotoxicity, the potentially incompatible pharmacokinetics of the two <br>compounds may also make the protective effect further be reduced [15].